Where Insulet Stands With Analysts
Portfolio Pulse from Benzinga Insights
In the last three months, 6 analysts have published ratings on Insulet (NASDAQ:PODD), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $223.67, down from $228.00. Recent analyst actions include both upgrades and downgrades in ratings and price targets. Insulet has shown strong financial performance with a 23.35% revenue growth rate, 11.66% net margin, and high ROE and ROA, but has a high debt-to-equity ratio of 1.77.
May 30, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Insulet (NASDAQ:PODD) has received mixed analyst ratings over the past three months, with a current average price target of $223.67, down from $228.00. The company has shown strong financial performance with a 23.35% revenue growth rate, 11.66% net margin, and high ROE and ROA, but has a high debt-to-equity ratio of 1.77.
The mixed analyst ratings and slight decrease in the average price target suggest a neutral short-term impact on Insulet's stock price. While the company has strong financial metrics, the high debt-to-equity ratio may be a concern for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100